Last week we discussed the balance-billing ban included in the Consolidated Appropriations Act that passed at the end of 2020. This week, we’re discussing another provision that was included in the CAA – a request for information regarding reporting on pharmacy benefits and prescription-drug costs. Marcy M. Buckner explains the RFI and our response to it, as well as some upcoming comment letters that NABIP will be submitting.
Do you have a topic you’d like us to cover or a question you would like us to address in an upcoming podcast? If so, send us an email here.